The store will not work correctly when cookies are disabled.
2-(4-Morpholinyl)-1-methyl-4-(4-nitrophenyl)-6-oxo-1,6-dihydropyrimidine-5-carbonitrile
ID: ALA2415058
PubChem CID: 45029179
Max Phase: Preclinical
Molecular Formula: C16H15N5O4
Molecular Weight: 341.33
Molecule Type: Small molecule
Associated Items:
Names and Identifiers
Canonical SMILES: Cn1c(N2CCOCC2)nc(-c2ccc([N+](=O)[O-])cc2)c(C#N)c1=O
Standard InChI: InChI=1S/C16H15N5O4/c1-19-15(22)13(10-17)14(11-2-4-12(5-3-11)21(23)24)18-16(19)20-6-8-25-9-7-20/h2-5H,6-9H2,1H3
Standard InChI Key: SXYPVUJNCILCAZ-UHFFFAOYSA-N
Molfile:
RDKit 2D
25 27 0 0 0 0 0 0 0 0999 V2000
4.1386 -11.4469 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
4.1386 -12.2719 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
4.8531 -12.6844 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
5.5675 -12.2719 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
5.5675 -11.4469 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
4.8531 -11.0344 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
4.8531 -10.2094 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
3.4241 -12.6844 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
3.4241 -11.0344 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
4.8531 -13.5094 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
2.7096 -13.0969 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
6.2820 -11.0344 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
6.9965 -11.4469 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
7.7109 -11.0344 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
7.7109 -10.2094 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
6.9965 -9.7969 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
6.2820 -10.2094 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
4.1386 -13.9219 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
4.1386 -14.7469 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
4.8531 -15.1594 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
5.5675 -14.7469 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
5.5675 -13.9219 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
4.8531 -15.9844 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
5.5675 -16.3969 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
4.1386 -16.3969 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
1 2 1 0
2 3 2 0
3 4 1 0
4 5 2 0
5 6 1 0
6 1 1 0
6 7 1 0
2 8 1 0
1 9 2 0
3 10 1 0
8 11 3 0
5 12 1 0
12 13 1 0
13 14 1 0
14 15 1 0
15 16 1 0
16 17 1 0
17 12 1 0
10 18 2 0
18 19 1 0
19 20 2 0
20 21 1 0
21 22 2 0
22 10 1 0
20 23 1 0
23 24 1 0
23 25 2 0
M CHG 2 23 1 24 -1
M END
Associated Targets(Human)
Associated Targets(non-human)
Molecule Features
Natural Product: No | Oral: No | Chemical Probe: No | Parenteral: No |
Molecule Type: Small molecule | Topical: No | First In Class: No | Black Box: No |
Chirality: No | Availability: No | Prodrug: No |
Drug Indications
MESH ID | MESH Heading | EFO IDs | EFO Terms | Max Phase for Indication | References |
---|
Mechanisms of Action
Mechanism of Action | Action Type | target ID | Target Name | Target Type | Target Organism | Binding Site Name | References |
---|
Calculated Properties
Molecular Weight: 341.33 | Molecular Weight (Monoisotopic): 341.1124 | AlogP: 1.06 | #Rotatable Bonds: 3 |
Polar Surface Area: 114.29 | Molecular Species: NEUTRAL | HBA: 8 | HBD: ┄ |
#RO5 Violations: ┄ | HBA (Lipinski): 9 | HBD (Lipinski): ┄ | #RO5 Violations (Lipinski): ┄ |
CX Acidic pKa: ┄ | CX Basic pKa: 0.87 | CX LogP: 0.81 | CX LogD: 0.81 |
Aromatic Rings: 2 | Heavy Atoms: 25 | QED Weighted: 0.61 | Np Likeness Score: -1.82 |
References
1. Fargualy AM, Habib NS, Ismail KA, Hassan AM, Sarg MT.. (2013) Synthesis, biological evaluation and molecular docking studies of some pyrimidine derivatives., 66 [PMID:23811090] [10.1016/j.ejmech.2013.05.028] |